# CCRT Combined With Endostar for the Treatment of Locally Advanced Cervical Cancer

> **NCT04121975** · PHASE2 · UNKNOWN · sponsor: **Zhejiang Cancer Hospital** · enrollment: 82 (estimated)

## Conditions studied

- Cervical Cancer

## Interventions

- **RADIATION:** Radiotherapy
- **DRUG:** Endostar
- **DRUG:** Cisplatin

## Key facts

- **NCT ID:** NCT04121975
- **Lead sponsor:** Zhejiang Cancer Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-08-01
- **Primary completion:** 2021-08
- **Final completion:** 2022-08
- **Target enrollment:** 82 (ESTIMATED)
- **Last updated:** 2019-10-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04121975

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04121975, "CCRT Combined With Endostar for the Treatment of Locally Advanced Cervical Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04121975. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*